Obamacare sign-up challenge: proving the law is not dead | | NOGALES, Arizona (Reuters) - More than two thousand miles away from the healthcare debate in Washington, President Donald Trump's threats to let Obamacare collapse are sowing confusion about its fate and dampening 2018 enrollment expectations. |
| |
Zika vaccine shows promise in early human trial | | CHICAGO (Reuters) - A DNA-based Zika vaccine from Inovio Pharmaceuticals Inc and South Korea's GeneOne Life Science Inc induced anti-Zika immune responses in an early stage human trial, U.S. researchers reported on Wednesday. |
| |
Insurers are slow to approve pricey new cholesterol drugs | | (Reuters Health) - During the first year an expensive class of new cholesterol-lowering drugs was on the market, only one in three patients with a prescription actually received the therapy due to lack of insurance approval and high copays, according to a study sponsored by a manufacturer of one such drug. |
| |
| | |